COMB157G2399: An Open-label, Single Arm, Multi-center Extension Study Evaluating Long-term Safety, Tolerability and Effectiveness of Ofatumumab in Subjects with Relapsing Multiple Sclerosis

April 07, 2021
https://clinicaltrials.gov/ct2/show/NCT03650114
Multiple Sclerosis
Principal Investigator: Mirela Cerghet, MD
Immune System Diseases, Autoimmune Diseases, Demyelinating Diseases, Autoimmune Diseases of the Nervous System, Multiple Sclerosis
Accepting Participants
313-916-1482